Nephrology
IgAN & C3G
Expert Perspectives in Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy: Complement-Mediated Kidney Diseases to Cover Key Topics in Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy Treatment
Overview
Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives in IgAN and C3G – Complement Mediated Kidney Diseases will feature community-selected experts and topics that we hope you will find of value in your clinical practice.
VIEW THE TOPICS
Expert Roundtables
- Current Treatments and Unmet Needs in Immunoglobulin A Nephropathy
- New Targets in Development for Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy
- Novel Approaches to Complement-Driven Renal Disease
- The Spectrum of Clinical Manifestations of Complementopathy
Clinical Topic Updates
- Autoantibodies and Genetic Influences in Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy
- Complement-Driven Renal Disease: Trials in Progress
- Monoclonal Gammopathy of Renal Significance as a Cause of Complement 3 Glomerulopathy
- Proximal Complement Inhibition in Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy
Patient Care Perspectives
- Complement 3 Glomerulopathy and Immunoglobulin A Nephropathy: Predictors of Progression
- Current Approaches and Outcomes in Complement-Mediated Renal Disease
- Infection as a Cause and a Consequence of Complement 3 Glomerulopathy
- The Role of Biopsy and Interpretation in the Diagnosis of Complement 3 Glomerulonephritis
